HGF and non-small cell lung carcinoma: In the present study, we attempted to determine whether metformin could be used as a therapeutic agent for overcoming HGF-induced alectinib resistance and further explored the mechanism underlying HGF overexpression in NSCLC cells with an ALK rearrangement.